Tokyo, Jan. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060412) titled 'Integrated Analysis of Radiomics and Molecular Profiling in malignant tumor... Read More
Tokyo, Jan. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060346) titled 'Safety Evaluation of Excessive Intake of the Ceramide-Containing Food' on J... Read More
Tokyo, Jan. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060413) titled 'Biopsychosocial factors associated with treatment decision-making for anti-... Read More
Tokyo, Jan. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060340) titled 'A Study on the Current Status of Small Bowel Endoscopy in Patients with Sma... Read More
Tokyo, Jan. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060406) titled 'Structural Validity of the Functional Assessment for Control of Trunk (FACT... Read More
Tokyo, Jan. 21 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060418) titled 'Effect of Step-Count-Targeted Physical Therapy on Prevention of Hospital-As... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07354919) titled 'Axelopran in Advanced Cancers' on Jan. 19. Study Type: Interventional Study ... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07355075) titled 'A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic De... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07355231) titled 'Lung Functional Avoidance Radiotherapy Using Hyperpolarized Xenon MRI' on Jan. ... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07355205) titled 'First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) i... Read More